Nodular densities after HAART introduction in an AIDS patient

Respiration

Volumn 69, Issue 3, 2002, Pages 283-285

  Naccache, Jean Marc ^a   Wislez, Marie ^a,b   Mayaud, Charles ^a,b   Cadranel, Jacques ^a,b  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

AIDS; Highly active antiretroviral therapy; Mycobacterium kasasii

Indexed keywords

ATOVAQUONE; CD4 ANTIGEN; COTRIMOXAZOLE; ETHAMBUTOL; INDINAVIR; ISONIAZID; LAMIVUDINE; METHYLPREDNISOLONE; PENTAMIDINE; RIFABUTIN; ZIDOVUDINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGRANULOCYTOSIS; ARTERIAL GAS; ARTICLE; BRONCHOSCOPY; CASE REPORT; CELL COUNT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HAEMOPHILUS INFLUENZAE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG LAVAGE; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM KANSASII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; THORAX RADIOGRAPHY; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; SPUTUM; VIRAL LOAD;

EID: 0036315842     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063637     Document Type: Article

References (11)

1. Incidence and clinical implications of isolation of Mycobacterium kansasii: Results of a 5-year, population-based study
2. Mycobacterium kansasii pulmonary infection in patients with AIDS: Spectrum of chest radiographic findings
3. Mycobacterium kansasii pulmonary infection: A prospective study of the results of nine months of treatment with rifampicin and ethambutol
4. Pulmonary Mycobacterium kan-sasiiinfection: Comparison of the clinical features, treatment and outcome with pulmonary tuberculosis
5. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease
6. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV Cohort Study
7. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS
8. Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy
9. Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis
10. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
11. Restoration of the immune system with anti-retroviral therapy